Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Preferred Shares (2017 - 2025)

Sunshine Biopharma (SBFM) has disclosed Preferred Shares for 10 consecutive years, with $13000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Preferred Shares changed 0.0% year-over-year to $13000.0, compared with a TTM value of $13000.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $13000.0, up 1200.0% over the prior year.
  • Preferred Shares was $13000.0 for Q3 2025 at Sunshine Biopharma, roughly flat from $13000.0 in the prior quarter.
  • Across five years, Preferred Shares topped out at $100000.0 in Q1 2021 and bottomed at $1000.0 in Q1 2022.
  • Average Preferred Shares over 5 years is $26263.2, with a median of $13000.0 recorded in 2024.
  • The sharpest move saw Preferred Shares crashed 99.0% in 2022, then skyrocketed 1200.0% in 2024.
  • Year by year, Preferred Shares stood at $100000.0 in 2021, then plummeted by 99.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 1200.0% to $13000.0 in 2024, then changed by 0.0% to $13000.0 in 2025.
  • Business Quant data shows Preferred Shares for SBFM at $13000.0 in Q3 2025, $13000.0 in Q2 2025, and $13000.0 in Q1 2025.